Long-Term Cardiovascular Risk in Patients With ANOCA: A Clinical Reality to Consider?

Chronic stable angina (CSA) remains one of the most frequent reasons for referral to diagnostic coronary angiography (CAG). In a substantial proportion of these patients, no obstructive coronary lesions or stenoses are identified, a condition referred to as angina with no obstructive coronary arteries (ANOCA). This group has been considered to be at higher cardiovascular risk (CVR), mainly due to persistent symptoms, a high burden of cardiovascular risk factors, and the potential presence of microvascular dysfunction or vasospasm. However, long-term evidence comparing their prognosis with that of the general population remains limited.

Pronóstico al año en lesiones ateroscleróticas vs las no ateroscleróticas en pacientes con MINOCA

In this context, the study by Olesen et al. provides long-term follow-up data aimed at evaluating 15-year CVR in patients with ANOCA referred for CAG due to stable angina, compared with a cohort from the general population. Data were obtained from Danish national registries and included patients ≥18 years of age who underwent elective CAG for suspected CSA between 2003 and 2021, in whom the absence of obstructive coronary artery disease (stenosis <50%) and no prior history of myocardial infarction (MI) were documented, thus defining the ANOCA cohort.

Each ANOCA case was matched in a 1:5 ratio by age and sex with individuals from the general population without a history of cardiovascular disease. The maximum follow-up was 15 years, with a mean follow-up of 10.7 years. Evaluated outcomes included MI, ischemic stroke, and all-cause mortality.

During long-term follow-up, the 15-year cumulative incidence of MI was identical in both cohorts (3.5% in ANOCA vs. 3.5% in the general population). The age- and sex-adjusted incidence rate ratio showed a trend toward a lower relative risk in the ANOCA group (IRR 0.89; 95% CI: 0.81–1.00). In contrast, the risk of ischemic stroke was slightly higher in patients with ANOCA (3.7% vs. 2.9%), with an absolute risk difference of 0.8% (95% CI: 0.5–1.2).

Read also: Perforation Management in Bifurcations: Bench Testing of Bailout with Covered Stents.

All-cause mortality was slightly lower in the ANOCA cohort compared with the general population (25.4% vs. 26.3%), with an absolute difference of −0.9% (95% CI: −1.8 to −0.1) and an IRR of 0.86 (95% CI: 0.83–0.90).

Stratified analyses showed that men and older patients (≥75 years) had more favorable risk profiles compared with the general population. In contrast, a specific subgroup—patients with diffuse non-obstructive coronary artery disease—exhibited a significantly increased risk of MI, ischemic stroke, and mortality, clearly differentiating them from patients with minimal or no coronary disease.

Conclusions

In this population-based observational study, patients with ANOCA exhibited a 15-year risk of MI similar to that of the general population, a slightly lower overall mortality, and a modestly increased risk of ischemic stroke. Importantly, subgroups with higher vulnerability were identified—particularly younger patients, women, and those with diffuse non-obstructive coronary artery disease—highlighting the need for more precise risk stratification in this population.

Original Title: 15-Year Cardiovascular Risk in Patients With Angina Without Obstructive Coronary Arteries.

Reference: Olesen KKW, Madsen M, Würtz M, Thim T, Mortensen MB, Sørensen HT, Maeng M. 15-Year Cardiovascular Risk in Patients With Angina Without Obstructive Coronary Arteries. JACC Cardiovasc Interv. 2025 Dec 22;18(24):3009-3020. doi: 10.1016/j.jcin.2025.09.014. Epub 2025 Nov 14. PMID: 41240023.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...

Comparison of strategies: NMA of IVUS, OCT, or angiography in complex lesions

Percutaneous coronary intervention (PCI) in complex lesions continues to represent a technical challenge in contemporary interventional cardiology. Angiography, although it remains the most widely...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

How real are the adverse effects of statins? Evidence from randomized clinical trials

The safety of statins continues to be a subject of debate, partly due to the extensive list of adverse effects included in prescribing information,...

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...